.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,840,924

« Back to Dashboard

Claims for Patent: 8,840,924

Title:Compositions and methods of making rapidly dissolving ionically masked formulations
Abstract: The present invention includes compositions and methods for reduce the taste of the drug in the drug resin complex. The composition may include one or more drug-resin complexes and a highly compressible, free-flowing pharmaceutical excipient. The resin is present in an amount effective to reduce the taste of the drug in the drug resin complex relative to an otherwise identical pharmaceutical composition without the resin; and wherein the highly compressible, free-flowing pharmaceutical excipient causes release of the drug-resin complex in the mouth.
Inventor(s): Tengler; Mark (Colleyville, TX), McMahen; Russell (Flower Mound, TX)
Assignee: NEOS Therapeutics, LP (Grand Prairie, TX)
Application Number:12/717,251
Patent Claims: 1. A compressed, orally disintegrating, controlled release taste-masked pharmaceutical composition comprising: a coated drug-ion-exchange resin complex and a directly compressible, free-flowing pharmaceutical excipient, wherein the composition effectively masks an unpalatable taste associated with delivery of the drug, wherein the coated drug-ion-exchange resin complex is coated with a controlled release coating, and wherein the directly compressible, free-flowing pharmaceutical excipient aids in the liberation of the coated drug-resin complex in the mouth through disintegration.

2. The composition of claim 1, wherein the drug in the drug-ion-exchange resin complex comprises dextromethorphan, codeine, morphine, hydrocodone, hyoscyamine, moguisteine, pseudoephedrine, chlorpheniramine, phenylprop anolamine, pharmaceutically acceptable salts of the same or combinations thereof.

3. The composition of claim 1, further comprising one or more flavorants, sweeteners, coolants, dyes, or combinations and mixtures thereof.

4. The composition of claim 1, further comprising one or more excipients, one or more binders or combinations and mixtures thereof.

5. The composition of claim 1, wherein the coated drug-ion-exchange resin complex comprises polistirex, polacrilex or combinations thereof.

6. The composition of claim 1, wherein the composition comprises pseudoephedrine polistirex and chlorpheniramine polacrilex.

7. The composition of claim 1, wherein the resin in the coated drug-ion-exchange resin complex comprises one or more cationic exchange resins.

8. The composition of claim 1, wherein the coated drug-ion-exchange resin complex comprises a divinylbenzene sulfonic acid cationic exchange resin.

9. The composition of claim 1, wherein the composition comprises a hardness of between about 5 and about 15 kPa.

10. The composition of claim 1, wherein the composition has at least about 20 percent better mouth-feel.

11. The composition of claim 1, wherein the coated drug-ion-exchange resin complex controlled release coating comprises a diffusion barrier coating.

12. The composition of claim 11, wherein the diffusion barrier coating is a time release coating.

13. A compressed, orally disintegrating, controlled release taste-masked hyoscyamine pharmaceutical composition according to claim 1 comprising: a coated hyoscyamine-ion-exchange resin complex; and a directly compressible, free-flowing pharmaceutical excipient that aids in the liberation of the coated hyoscyamine-ion-exchange resin complex in the mouth through disintegration.

14. The composition of claim 13, further comprising one or more flavorants, sweeteners, coolants, dyes, or combinations and mixtures thereof.

15. The composition of claim 13, further comprising one or more excipients, one or more binders or combinations and mixtures thereof.

16. The composition of claim 1, wherein the directly compressible, free-flowing pharmaceutical excipient comprises a water-soluble compressible carbohydrate.

17. The composition of claim 1, further comprising one or more amorphous sugars.

18. The composition of claim 1, further comprising a plasticizer.

19. The composition of claim 1, wherein said controlled release coating comprises a delayed release coating.

20. The composition of claim 19, wherein the drug in said drug-ion-exchange resin complex comprises an analgesic drug, anti-inflammatory drug, central nervous system agent, anti-hypertensive drug, or an anti-hyperactive drug.

21. The composition of claim 20, wherein the drug in said drug-ion-exchange resin complex comprises an anti-hyperactive drug.

22. The composition of claim 19, wherein the drug in said drug-ion-exchange resin complex comprises amphetamine.

23. The composition of claim 1, wherein the drug in said drug-ion-exchange resin complex comprises an analgesic drug, anti-inflammatory drug, central nervous system agent, anti-hypertensive drug, or an anti-hyperactive drug.

24. The composition of claim 23, wherein the drug in said drug-ion-exchange resin complex comprises an anti-hyperactive drug.

25. The composition of claim 1, wherein the drug in said drug-ion-exchange resin complex comprises amphetamine.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc